SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

26 Jul 2024 Evaluate
A fair growth of 11.52% in the revenue at Rs. 325.36 millions was reported in the June 2024 quarter as compared to Rs. 291.75 millions during year-ago period.Net Profit recorded in the quarter ended June 2024 rise to 38.11% to Rs. 74.15  millions  compared to R. 53.69 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 106.94 millions from 80.04 millions in the quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 325.36 291.75 11.52 325.36 291.75 11.52 1419.66 1367.49 3.82
Other Income 14.06 10.37 35.58 14.06 10.37 35.58 46.67 51.23 -8.90
PBIDT 106.94 80.04 33.61 106.94 80.04 33.61 377.85 354.90 6.47
Interest 1.15 0.74 55.41 1.15 0.74 55.41 2.71 3.67 -26.16
PBDT 105.79 79.30 33.40 105.79 79.30 33.40 375.14 351.23 6.81
Depreciation 5.19 5.00 3.80 5.19 5.00 3.80 23.40 22.59 3.59
PBT 100.60 74.30 35.40 100.60 74.30 35.40 351.74 328.64 7.03
TAX 26.45 20.61 28.34 26.45 20.61 28.34 91.98 82.58 11.38
Deferred Tax 1.45 0.59 145.76 1.45 0.59 145.76 -5.21 -2.25 131.56
PAT 74.15 53.69 38.11 74.15 53.69 38.11 259.76 246.06 5.57
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 32.87 27.43 19.81 32.87 27.43 19.81 26.62 25.95 2.55

Jenburkt Pharma Share Price

1061.80 11.40 (1.09%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×